img

Global Transdermal Analgesics Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Transdermal Analgesics Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Transdermal Analgesics report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Transdermal Analgesics market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Pharmacy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Transdermal Analgesics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Transdermal Analgesics key manufacturers include Abbott Laboratories, AbbVie Inc., Bayer AG, Eli Lilly and Company, endo pharmaceuticals, Glaxosmithkline plc, johnson and johnson md&d, Pfizer, Inc., Reckitt Benckiser Group and Sanofi, etc. Abbott Laboratories, AbbVie Inc., Bayer AG are top 3 players and held % sales share in total in 2022.
Transdermal Analgesics can be divided into Non opioids and Opioids, etc. Non opioids is the mainstream product in the market, accounting for % sales share globally in 2022.
Transdermal Analgesics is widely used in various fields, such as Hospital, Pharmacy and Family,, etc. Hospital provides greatest supports to the Transdermal Analgesics industry development. In 2022, global % sales of Transdermal Analgesics went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transdermal Analgesics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Abbott Laboratories
AbbVie Inc.
Bayer AG
Eli Lilly and Company
endo pharmaceuticals, Glaxosmithkline plc
johnson and johnson md&d
Pfizer, Inc.
Reckitt Benckiser Group
Sanofi
Segment by Type
Non opioids
Opioids

Segment by Application


Hospital
Pharmacy
Family

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Transdermal Analgesics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Transdermal Analgesics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Transdermal Analgesics industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Transdermal Analgesics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Transdermal Analgesics introduction, etc. Transdermal Analgesics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Transdermal Analgesics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Transdermal Analgesics Market Overview
1.1 Transdermal Analgesics Product Overview
1.2 Transdermal Analgesics Market Segment by Type
1.2.1 Non opioids
1.2.2 Opioids
1.3 Global Transdermal Analgesics Market Size by Type
1.3.1 Global Transdermal Analgesics Market Size Overview by Type (2024-2034)
1.3.2 Global Transdermal Analgesics Historic Market Size Review by Type (2024-2024)
1.3.3 Global Transdermal Analgesics Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Transdermal Analgesics Sales Breakdown by Type (2024-2024)
1.4.2 Europe Transdermal Analgesics Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Transdermal Analgesics Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Transdermal Analgesics Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Transdermal Analgesics Sales Breakdown by Type (2024-2024)
2 Global Transdermal Analgesics Market Competition by Company
2.1 Global Top Players by Transdermal Analgesics Sales (2024-2024)
2.2 Global Top Players by Transdermal Analgesics Revenue (2024-2024)
2.3 Global Top Players by Transdermal Analgesics Price (2024-2024)
2.4 Global Top Manufacturers Transdermal Analgesics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Transdermal Analgesics Market Competitive Situation and Trends
2.5.1 Transdermal Analgesics Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Transdermal Analgesics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Analgesics as of 2022)
2.7 Date of Key Manufacturers Enter into Transdermal Analgesics Market
2.8 Key Manufacturers Transdermal Analgesics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Transdermal Analgesics Status and Outlook by Region
3.1 Global Transdermal Analgesics Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Transdermal Analgesics Historic Market Size by Region
3.2.1 Global Transdermal Analgesics Sales in Volume by Region (2024-2024)
3.2.2 Global Transdermal Analgesics Sales in Value by Region (2024-2024)
3.2.3 Global Transdermal Analgesics Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Transdermal Analgesics Forecasted Market Size by Region
3.3.1 Global Transdermal Analgesics Sales in Volume by Region (2024-2034)
3.3.2 Global Transdermal Analgesics Sales in Value by Region (2024-2034)
3.3.3 Global Transdermal Analgesics Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Transdermal Analgesics by Application
4.1 Transdermal Analgesics Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.1.3 Family
4.2 Global Transdermal Analgesics Market Size by Application
4.2.1 Global Transdermal Analgesics Market Size Overview by Application (2024-2034)
4.2.2 Global Transdermal Analgesics Historic Market Size Review by Application (2024-2024)
4.2.3 Global Transdermal Analgesics Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Transdermal Analgesics Sales Breakdown by Application (2024-2024)
4.3.2 Europe Transdermal Analgesics Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Transdermal Analgesics Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Transdermal Analgesics Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Transdermal Analgesics Sales Breakdown by Application (2024-2024)
5 North America Transdermal Analgesics by Country
5.1 North America Transdermal Analgesics Historic Market Size by Country
5.1.1 North America Transdermal Analgesics Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Transdermal Analgesics Sales in Volume by Country (2024-2024)
5.1.3 North America Transdermal Analgesics Sales in Value by Country (2024-2024)
5.2 North America Transdermal Analgesics Forecasted Market Size by Country
5.2.1 North America Transdermal Analgesics Sales in Volume by Country (2024-2034)
5.2.2 North America Transdermal Analgesics Sales in Value by Country (2024-2034)
6 Europe Transdermal Analgesics by Country
6.1 Europe Transdermal Analgesics Historic Market Size by Country
6.1.1 Europe Transdermal Analgesics Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Transdermal Analgesics Sales in Volume by Country (2024-2024)
6.1.3 Europe Transdermal Analgesics Sales in Value by Country (2024-2024)
6.2 Europe Transdermal Analgesics Forecasted Market Size by Country
6.2.1 Europe Transdermal Analgesics Sales in Volume by Country (2024-2034)
6.2.2 Europe Transdermal Analgesics Sales in Value by Country (2024-2034)
7 Asia-Pacific Transdermal Analgesics by Region
7.1 Asia-Pacific Transdermal Analgesics Historic Market Size by Region
7.1.1 Asia-Pacific Transdermal Analgesics Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Transdermal Analgesics Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Transdermal Analgesics Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Transdermal Analgesics Forecasted Market Size by Region
7.2.1 Asia-Pacific Transdermal Analgesics Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Transdermal Analgesics Sales in Value by Region (2024-2034)
8 Latin America Transdermal Analgesics by Country
8.1 Latin America Transdermal Analgesics Historic Market Size by Country
8.1.1 Latin America Transdermal Analgesics Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Transdermal Analgesics Sales in Volume by Country (2024-2024)
8.1.3 Latin America Transdermal Analgesics Sales in Value by Country (2024-2024)
8.2 Latin America Transdermal Analgesics Forecasted Market Size by Country
8.2.1 Latin America Transdermal Analgesics Sales in Volume by Country (2024-2034)
8.2.2 Latin America Transdermal Analgesics Sales in Value by Country (2024-2034)
9 Middle East and Africa Transdermal Analgesics by Country
9.1 Middle East and Africa Transdermal Analgesics Historic Market Size by Country
9.1.1 Middle East and Africa Transdermal Analgesics Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Transdermal Analgesics Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Transdermal Analgesics Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Transdermal Analgesics Forecasted Market Size by Country
9.2.1 Middle East and Africa Transdermal Analgesics Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Transdermal Analgesics Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Company Information
10.1.2 Abbott Laboratories Introduction and Business Overview
10.1.3 Abbott Laboratories Transdermal Analgesics Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Abbott Laboratories Transdermal Analgesics Products Offered
10.1.5 Abbott Laboratories Recent Development
10.2 AbbVie Inc.
10.2.1 AbbVie Inc. Company Information
10.2.2 AbbVie Inc. Introduction and Business Overview
10.2.3 AbbVie Inc. Transdermal Analgesics Sales, Revenue and Gross Margin (2024-2024)
10.2.4 AbbVie Inc. Transdermal Analgesics Products Offered
10.2.5 AbbVie Inc. Recent Development
10.3 Bayer AG
10.3.1 Bayer AG Company Information
10.3.2 Bayer AG Introduction and Business Overview
10.3.3 Bayer AG Transdermal Analgesics Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Bayer AG Transdermal Analgesics Products Offered
10.3.5 Bayer AG Recent Development
10.4 Eli Lilly and Company
10.4.1 Eli Lilly and Company Company Information
10.4.2 Eli Lilly and Company Introduction and Business Overview
10.4.3 Eli Lilly and Company Transdermal Analgesics Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Eli Lilly and Company Transdermal Analgesics Products Offered
10.4.5 Eli Lilly and Company Recent Development
10.5 endo pharmaceuticals, Glaxosmithkline plc
10.5.1 endo pharmaceuticals, Glaxosmithkline plc Company Information
10.5.2 endo pharmaceuticals, Glaxosmithkline plc Introduction and Business Overview
10.5.3 endo pharmaceuticals, Glaxosmithkline plc Transdermal Analgesics Sales, Revenue and Gross Margin (2024-2024)
10.5.4 endo pharmaceuticals, Glaxosmithkline plc Transdermal Analgesics Products Offered
10.5.5 endo pharmaceuticals, Glaxosmithkline plc Recent Development
10.6 johnson and johnson md&d
10.6.1 johnson and johnson md&d Company Information
10.6.2 johnson and johnson md&d Introduction and Business Overview
10.6.3 johnson and johnson md&d Transdermal Analgesics Sales, Revenue and Gross Margin (2024-2024)
10.6.4 johnson and johnson md&d Transdermal Analgesics Products Offered
10.6.5 johnson and johnson md&d Recent Development
10.7 Pfizer, Inc.
10.7.1 Pfizer, Inc. Company Information
10.7.2 Pfizer, Inc. Introduction and Business Overview
10.7.3 Pfizer, Inc. Transdermal Analgesics Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Pfizer, Inc. Transdermal Analgesics Products Offered
10.7.5 Pfizer, Inc. Recent Development
10.8 Reckitt Benckiser Group
10.8.1 Reckitt Benckiser Group Company Information
10.8.2 Reckitt Benckiser Group Introduction and Business Overview
10.8.3 Reckitt Benckiser Group Transdermal Analgesics Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Reckitt Benckiser Group Transdermal Analgesics Products Offered
10.8.5 Reckitt Benckiser Group Recent Development
10.9 Sanofi
10.9.1 Sanofi Company Information
10.9.2 Sanofi Introduction and Business Overview
10.9.3 Sanofi Transdermal Analgesics Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Sanofi Transdermal Analgesics Products Offered
10.9.5 Sanofi Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Transdermal Analgesics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Transdermal Analgesics Industrial Chain Analysis
11.4 Transdermal Analgesics Market Dynamics
11.4.1 Transdermal Analgesics Industry Trends
11.4.2 Transdermal Analgesics Market Drivers
11.4.3 Transdermal Analgesics Market Challenges
11.4.4 Transdermal Analgesics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Transdermal Analgesics Distributors
12.3 Transdermal Analgesics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Non opioids
Table 2. Major Company of Opioids
Table 3. Global Transdermal Analgesics Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Transdermal Analgesics Sales by Type (2024-2024) & (K Units)
Table 5. Global Transdermal Analgesics Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Transdermal Analgesics Sales by Type (2024-2024) & (US& Million)
Table 7. Global Transdermal Analgesics Market Share in Value by Type (2024-2024)
Table 8. Global Transdermal Analgesics Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Transdermal Analgesics Sales by Type (2024-2034) & (K Units)
Table 10. Global Transdermal Analgesics Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Transdermal Analgesics Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Transdermal Analgesics Sales Market Share in Value by Type (2024-2034)
Table 13. Global Transdermal Analgesics Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Transdermal Analgesics Sales by Type (2024-2024) & (K Units)
Table 15. North America Transdermal Analgesics Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Transdermal Analgesics Sales (K Units) by Type (2024-2024)
Table 17. Europe Transdermal Analgesics Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Transdermal Analgesics Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Transdermal Analgesics Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Transdermal Analgesics Sales (K Units) by Type (2024-2024)
Table 21. Latin America Transdermal Analgesics Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Transdermal Analgesics Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Transdermal Analgesics Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Transdermal Analgesics Sales by Company (2024-2024) & (K Units)
Table 25. Global Transdermal Analgesics Sales Share by Company (2024-2024)
Table 26. Global Transdermal Analgesics Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Transdermal Analgesics Revenue Share by Company (2024-2024)
Table 28. Global Market Transdermal Analgesics Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Transdermal Analgesics Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Transdermal Analgesics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Analgesics as of 2022)
Table 32. Date of Key Manufacturers Enter into Transdermal Analgesics Market
Table 33. Key Manufacturers Transdermal Analgesics Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Transdermal Analgesics Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Transdermal Analgesics Sales by Region (2024-2024) & (K Units)
Table 37. Global Transdermal Analgesics Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Transdermal Analgesics Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Transdermal Analgesics Sales Market Share in Value by Region (2024-2024)
Table 40. Global Transdermal Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Transdermal Analgesics Sales by Region (2024-2034) & (K Units)
Table 42. Global Transdermal Analgesics Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Transdermal Analgesics Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Transdermal Analgesics Sales Market Share in Value by Region (2024-2034)
Table 45. Global Transdermal Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Transdermal Analgesics Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Transdermal Analgesics Sales by Application (2024-2024) & (K Units)
Table 48. Global Transdermal Analgesics Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Transdermal Analgesics Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Transdermal Analgesics Sales Market Share in Value by Application (2024-2024)
Table 51. Global Transdermal Analgesics Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Transdermal Analgesics Sales by Application (2024-2034) & (K Units)
Table 53. Global Transdermal Analgesics Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Transdermal Analgesics Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Transdermal Analgesics Sales Market Share in Value by Application (2024-2034)
Table 56. Global Transdermal Analgesics Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Transdermal Analgesics Sales by Application (2024-2024) (K Units)
Table 58. North America Transdermal Analgesics Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Transdermal Analgesics Sales by Application (2024-2024) (K Units)
Table 60. Europe Transdermal Analgesics Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Transdermal Analgesics Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Transdermal Analgesics Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Transdermal Analgesics Sales by Application (2024-2024) (K Units)
Table 64. Latin America Transdermal Analgesics Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Transdermal Analgesics Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Transdermal Analgesics Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Transdermal Analgesics Sales by Country (2024-2024) & (K Units)
Table 68. North America Transdermal Analgesics Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Transdermal Analgesics Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Transdermal Analgesics Sales Market Share in Value by Country (2024-2024)
Table 71. North America Transdermal Analgesics Sales by Country (2024-2034) & (K Units)
Table 72. North America Transdermal Analgesics Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Transdermal Analgesics Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Transdermal Analgesics Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Transdermal Analgesics Sales by Country (2024-2024) & (K Units)
Table 76. Europe Transdermal Analgesics Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Transdermal Analgesics Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Transdermal Analgesics Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Transdermal Analgesics Sales by Country (2024-2034) & (K Units)
Table 80. Europe Transdermal Analgesics Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Transdermal Analgesics Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Transdermal Analgesics Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Transdermal Analgesics Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Transdermal Analgesics Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Transdermal Analgesics Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Transdermal Analgesics Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Transdermal Analgesics Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Transdermal Analgesics Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Transdermal Analgesics Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Transdermal Analgesics Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Transdermal Analgesics Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Transdermal Analgesics Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Transdermal Analgesics Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Transdermal Analgesics Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Transdermal Analgesics Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Transdermal Analgesics Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Transdermal Analgesics Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Transdermal Analgesics Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Transdermal Analgesics Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Transdermal Analgesics Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Transdermal Analgesics Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Transdermal Analgesics Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Transdermal Analgesics Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Transdermal Analgesics Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Transdermal Analgesics Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Transdermal Analgesics Sales Market Share in Value by Country (2024-2034)
Table 107. Abbott Laboratories Company Information
Table 108. Abbott Laboratories Introduction and Business Overview
Table 109. Abbott Laboratories Transdermal Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Abbott Laboratories Transdermal Analgesics Product
Table 111. Abbott Laboratories Recent Development
Table 112. AbbVie Inc. Company Information
Table 113. AbbVie Inc. Introduction and Business Overview
Table 114. AbbVie Inc. Transdermal Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. AbbVie Inc. Transdermal Analgesics Product
Table 116. AbbVie Inc. Recent Development
Table 117. Bayer AG Company Information
Table 118. Bayer AG Introduction and Business Overview
Table 119. Bayer AG Transdermal Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Bayer AG Transdermal Analgesics Product
Table 121. Bayer AG Recent Development
Table 122. Eli Lilly and Company Company Information
Table 123. Eli Lilly and Company Introduction and Business Overview
Table 124. Eli Lilly and Company Transdermal Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Eli Lilly and Company Transdermal Analgesics Product
Table 126. Eli Lilly and Company Recent Development
Table 127. endo pharmaceuticals, Glaxosmithkline plc Company Information
Table 128. endo pharmaceuticals, Glaxosmithkline plc Introduction and Business Overview
Table 129. endo pharmaceuticals, Glaxosmithkline plc Transdermal Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. endo pharmaceuticals, Glaxosmithkline plc Transdermal Analgesics Product
Table 131. endo pharmaceuticals, Glaxosmithkline plc Recent Development
Table 132. johnson and johnson md&d Company Information
Table 133. johnson and johnson md&d Introduction and Business Overview
Table 134. johnson and johnson md&d Transdermal Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. johnson and johnson md&d Transdermal Analgesics Product
Table 136. johnson and johnson md&d Recent Development
Table 137. Pfizer, Inc. Company Information
Table 138. Pfizer, Inc. Introduction and Business Overview
Table 139. Pfizer, Inc. Transdermal Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Pfizer, Inc. Transdermal Analgesics Product
Table 141. Pfizer, Inc. Recent Development
Table 142. Reckitt Benckiser Group Company Information
Table 143. Reckitt Benckiser Group Introduction and Business Overview
Table 144. Reckitt Benckiser Group Transdermal Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Reckitt Benckiser Group Transdermal Analgesics Product
Table 146. Reckitt Benckiser Group Recent Development
Table 147. Sanofi Company Information
Table 148. Sanofi Introduction and Business Overview
Table 149. Sanofi Transdermal Analgesics Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Sanofi Transdermal Analgesics Product
Table 151. Sanofi Recent Development
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Transdermal Analgesics Market Trends
Table 155. Transdermal Analgesics Market Drivers
Table 156. Transdermal Analgesics Market Challenges
Table 157. Transdermal Analgesics Market Restraints
Table 158. Transdermal Analgesics Distributors List
Table 159. Transdermal Analgesics Downstream Customers
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Analgesics Product Picture
Figure 2. Global Transdermal Analgesics Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Transdermal Analgesics Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Transdermal Analgesics Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Non opioids
Figure 6. Global Non opioids Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Opioids
Figure 8. Global Opioids Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Transdermal Analgesics Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Transdermal Analgesics Sales Market Share by Type in 2022 & 2034
Figure 11. North America Transdermal Analgesics Sales Market Share in Volume by Type in 2022
Figure 12. North America Transdermal Analgesics Sales Market Share in Value by Type in 2022
Figure 13. Europe Transdermal Analgesics Sales Market Share in Volume by Type in 2022
Figure 14. Europe Transdermal Analgesics Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Transdermal Analgesics Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Transdermal Analgesics Sales Market Share in Value by Type in 2022
Figure 17. Latin America Transdermal Analgesics Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Transdermal Analgesics Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Transdermal Analgesics Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Transdermal Analgesics Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Transdermal Analgesics Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Transdermal Analgesics Revenue in 2022
Figure 23. Transdermal Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Pharmacy
Figure 27. Global Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Family
Figure 29. Global Family Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Transdermal Analgesics Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Transdermal Analgesics Sales Market Share by Application in 2022 & 2034
Figure 32. North America Transdermal Analgesics Sales Market Share in Volume by Application in 2022
Figure 33. North America Transdermal Analgesics Sales Market Share in Value by Application in 2022
Figure 34. Europe Transdermal Analgesics Sales Market Share in Volume by Application in 2022
Figure 35. Europe Transdermal Analgesics Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Transdermal Analgesics Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Transdermal Analgesics Sales Market Share in Value by Application in 2022
Figure 38. Latin America Transdermal Analgesics Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Transdermal Analgesics Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Transdermal Analgesics Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Transdermal Analgesics Manufacturing Cost Structure
Figure 43. Transdermal Analgesics Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed